Jazz Pharmaceuticals Plc
(NASDAQ) JAZZ
Jazz Pharmaceuticals Plc Financials at a Glance
Market Cap
$12.56B
Revenue (TTM)
$4.27B
Net Income (TTM)
$356.15M
EPS (TTM)
$-5.97
P/E Ratio
-34.17
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$199.95
Volume
24,334
Open
$202.37
Price
$199.95
Volume
24,334
Open
$202.37
Previous Close
$199.95
Daily Range
$198.97 - $205.00
52-Week Range
$97.50 - $207.48
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$199.95
Volume
24,334
Open
$202.37
Previous Close
$199.95
Daily Range
$198.97 - $205.00
52-Week Range
$97.50 - $207.48
JAZZ News
JAZZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jazz Pharmaceuticals Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,890
CEO
Renée D. Galá, MBA
Website
www.jazzpharma.comHeadquarters
Dublin, 4, IE
JAZZ Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
5%
Net Income Margin
-8%
Return on Equity
-8%
Return on Capital
2%
Return on Assets
-3%
Earnings Yield
-2.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.56B
Shares Outstanding
61.56M
Volume
24.33K
Avg. Volume
954.14K
Financials (TTM)
Gross Profit
$3.76B
Operating Income
$224.42M
EBITDA
$108.46M
Operating Cash Flow
$1.36B
Capital Expenditure
$58.75M
Free Cash Flow
$1.30B
Cash & ST Invst.
$2.44B
Total Debt
$5.42B
Jazz Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.20B
+10.1%
Gross Profit
$1.17B
+22.3%
Gross Margin
97.94%
N/A
Market Cap
$12.56B
N/A
Market Cap/Employee
$4.48M
N/A
Employees
2,800
N/A
Net Income
$203.45M
+6.5%
EBITDA
$278.56M
-29.8%
Quarterly Fundamentals
Net Cash
$2.97B
+6.4%
Accounts Receivable
$830.75M
+15.9%
Inventory
$416.96M
-13.2%
Long Term Debt
$4.38B
-28.4%
Short Term Debt
$1.03B
+2149.7%
Return on Assets
-3.05%
N/A
Return on Invested Capital
2.38%
N/A
Free Cash Flow
$296.79M
-23.0%
Operating Cash Flow
$362.52M
-9.0%